|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4309989A
(en)
|
1976-02-09 |
1982-01-12 |
The Curators Of The University Of Missouri |
Topical application of medication by ultrasound with coupling agent
|
|
FR2374910A1
(fr)
|
1976-10-23 |
1978-07-21 |
Choay Sa |
Preparation a base d'heparine, comprenant des liposomes, procede pour l'obtenir et medicaments contenant de telles preparations
|
|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
|
US4656134A
(en)
|
1982-01-11 |
1987-04-07 |
Board Of Trustees Of Leland Stanford Jr. University |
Gene amplification in eukaryotic cells
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US4965188A
(en)
|
1986-08-22 |
1990-10-23 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
|
|
US4766067A
(en)
|
1985-05-31 |
1988-08-23 |
President And Fellows Of Harvard College |
Gene amplification
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US4800159A
(en)
|
1986-02-07 |
1989-01-24 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences
|
|
US4767402A
(en)
|
1986-07-08 |
1988-08-30 |
Massachusetts Institute Of Technology |
Ultrasound enhancement of transdermal drug delivery
|
|
EP0545913B1
(en)
|
1986-08-18 |
1999-02-24 |
Emisphere Technologies, Inc. |
Delivery systems for pharmacological agents
|
|
US4889818A
(en)
|
1986-08-22 |
1989-12-26 |
Cetus Corporation |
Purified thermostable enzyme
|
|
US4921794A
(en)
|
1987-01-14 |
1990-05-01 |
President And Fellows Of Harvard College |
T7 DNA polymerase
|
|
US4795699A
(en)
|
1987-01-14 |
1989-01-03 |
President And Fellows Of Harvard College |
T7 DNA polymerase
|
|
US5130238A
(en)
|
1988-06-24 |
1992-07-14 |
Cangene Corporation |
Enhanced nucleic acid amplification process
|
|
US5091310A
(en)
|
1988-09-23 |
1992-02-25 |
Cetus Corporation |
Structure-independent dna amplification by the polymerase chain reaction
|
|
US5066584A
(en)
|
1988-09-23 |
1991-11-19 |
Cetus Corporation |
Methods for generating single stranded dna by the polymerase chain reaction
|
|
US5142033A
(en)
|
1988-09-23 |
1992-08-25 |
Hoffmann-La Roche Inc. |
Structure-independent DNA amplification by the polymerase chain reaction
|
|
US4994370A
(en)
|
1989-01-03 |
1991-02-19 |
The United States Of America As Represented By The Department Of Health And Human Services |
DNA amplification technique
|
|
US5266491A
(en)
|
1989-03-14 |
1993-11-30 |
Mochida Pharmaceutical Co., Ltd. |
DNA fragment and expression plasmid containing the DNA fragment
|
|
US5580575A
(en)
|
1989-12-22 |
1996-12-03 |
Imarx Pharmaceutical Corp. |
Therapeutic drug delivery systems
|
|
US5580734A
(en)
|
1990-07-13 |
1996-12-03 |
Transkaryotic Therapies, Inc. |
Method of producing a physical map contigous DNA sequences
|
|
US5733761A
(en)
|
1991-11-05 |
1998-03-31 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
|
US5641670A
(en)
|
1991-11-05 |
1997-06-24 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
|
US5643252A
(en)
|
1992-10-28 |
1997-07-01 |
Venisect, Inc. |
Laser perforator
|
|
US5849695A
(en)
|
1993-01-13 |
1998-12-15 |
The Regents Of The University Of California |
Parathyroid hormone analogues useful for treatment of osteoporosis and disorders of calcium meatabolism in mammals
|
|
CZ206195A3
(en)
|
1993-02-12 |
1996-04-17 |
Univ Leland Stanford Junior |
Controlled transcription of target genes and other biological materials
|
|
US5514670A
(en)
|
1993-08-13 |
1996-05-07 |
Pharmos Corporation |
Submicron emulsions for delivery of peptides
|
|
US5814599A
(en)
|
1995-08-04 |
1998-09-29 |
Massachusetts Insitiute Of Technology |
Transdermal delivery of encapsulated drugs
|
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
|
US6218185B1
(en)
|
1996-04-19 |
2001-04-17 |
The United States Of America As Represented By The Secretary Of Agriculture |
Piggybac transposon-based genetic transformation system for insects
|
|
US5827729A
(en)
|
1996-04-23 |
1998-10-27 |
Advanced Tissue Sciences |
Diffusion gradient bioreactor and extracorporeal liver device using a three-dimensional liver tissue
|
|
US5879681A
(en)
|
1997-02-07 |
1999-03-09 |
Emisphere Technolgies Inc. |
Compounds and compositions for delivering active agents
|
|
IL120943A
(en)
|
1997-05-29 |
2004-03-28 |
Univ Ben Gurion |
A system for administering drugs through the skin
|
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
|
US6962810B2
(en)
|
2000-10-31 |
2005-11-08 |
University Of Notre Dame Du Lac |
Methods and compositions for transposition using minimal segments of the eukaryotic transformation vector piggyBac
|
|
EP2160461B1
(en)
|
2007-07-04 |
2012-08-08 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Hyperactive variants of the transposase protein of the transposon system sleeping beauty
|
|
WO2010099296A1
(en)
|
2009-02-26 |
2010-09-02 |
Transposagen Biopharmaceuticals, Inc. |
Hyperactive piggybac transposases
|
|
US20120156170A1
(en)
*
|
2009-08-31 |
2012-06-21 |
Tadashi Tanabe |
Drug composition for angiogenesis therapy
|
|
US20130023033A1
(en)
|
2010-03-29 |
2013-01-24 |
The Trustees Of The University Of Pennsylvania |
Pharmacologically induced transgene ablation system
|
|
WO2012050919A2
(en)
*
|
2010-09-28 |
2012-04-19 |
The University Of Notre Dame |
Chimeric spider silk and uses thereof
|
|
WO2012074758A1
(en)
*
|
2010-11-16 |
2012-06-07 |
Transposagen Bioharmaceuticals, Inc. |
Hyperactive piggybac transposases
|
|
AU2013281328B2
(en)
*
|
2012-06-27 |
2017-11-23 |
MeiraGTx Gene Regulation Limited |
Combination for treating an inflammatory disorder
|
|
WO2014143884A2
(en)
|
2013-03-15 |
2014-09-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Synthetic methylmalonyl-coa mutase transgene for the treatment of mut class methylmalonic acidemia (mma)
|
|
RS60902B1
(sr)
|
2014-03-09 |
2020-11-30 |
Univ Pennsylvania |
Kompozicije korisne u lečenju nedostatka ornitinske transkarbamilaze (otc)
|
|
CA2943296C
(en)
*
|
2014-03-21 |
2022-10-18 |
The Sydney Children's Hospitals Network (Randwick And Westmead) (Incorporating The Royal Alexandra Hospital For Children) |
Stable gene transfer to proliferating cells
|
|
US10927384B2
(en)
|
2014-04-09 |
2021-02-23 |
Dna Twopointo Inc. |
DNA vectors, transposons and transposases for eukaryotic genome modification
|
|
KR20180034467A
(ko)
|
2015-08-03 |
2018-04-04 |
마이오도파 리미티드 |
L-dopa의 전신 합성 및 조절
|
|
US20170112108A1
(en)
*
|
2015-10-22 |
2017-04-27 |
Hera Testing Laboratories, Inc. |
Genetically modified non-human mammals having modified liver cells and/or tissue and methods of making same
|
|
WO2017099838A1
(en)
|
2015-12-11 |
2017-06-15 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Gene therapy for combined methylmalonic acidemia/aciduria and hyperhomocysteinemia/homocystinuria, cobalamin c type, and deficiency of mmachc
|
|
EP3680280A4
(en)
|
2017-09-05 |
2021-06-02 |
Toray Industries, Inc. |
FIBER REINFORCED THERMOPLASTIC RESIN MOLDINGS
|
|
KR102849343B1
(ko)
*
|
2018-03-07 |
2025-08-25 |
포세이다 테라퓨틱스, 인크. |
Cartyrin 조성물 및 사용 방법
|
|
EP3847197A1
(en)
|
2018-09-05 |
2021-07-14 |
Poseida Therapeutics, Inc. |
Allogeneic cell compositions and methods of use
|